Form 4 for INBS INTELLIGENT BIO SOLUTIONS INC.
Accepted 2022-10-12 00:00:00 ET · period of report 2022-10-10 · accession 0001493152-22-028189 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-10-12 | 2022-10-10 | INBS | Boyages Steven Constantine | COB, Interim CEO, Dir | A - Grant | $0.00 | +75.0K | 75.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.01 per share | 2022-10-10 | A | A | 75,000 | $0.00 | 75,000 | D | — | — |